
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 836 | 831 | 972 | 1209 | 1792 | 2347 |
Fund Return | -16.37% | -16.93% | -2.76% | 6.52% | 12.37% | 8.91% |
Place in category | 576 | 562 | 212 | 103 | 77 | 11 |
% in Category | 89 | 87 | 28 | 21 | 19 | 7 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
KI Midcap Fund A USD Acc | 3.28B | -16.51 | 5.42 | 7.78 | ||
KI Midcap Fund B USD Acc | 3.28B | -16.51 | 5.42 | 7.45 | ||
KI Midcap Fund I USD Acc | 3.28B | -16.50 | 5.46 | 7.82 | ||
WB US Small Mid Cap Growth Fund Cla | 839.93M | -3.58 | 3.63 | 10.18 | ||
Artemis US Ext Alpha B acc USD | 469.45M | 24.99 | 8.18 | 13.13 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC Indian Eq ADHKD | 1.22B | -12.03 | 4.22 | 4.12 | ||
GS India Equity Portfolio Base Acc | 4.72B | -15.12 | 5.25 | 7.31 | ||
GS India Equity Portfolio Base Inc | 4.72B | -15.14 | 5.25 | 7.31 | ||
GS India Equity Portfolio I A Inc | 4.72B | -15.20 | 4.72 | 6.78 | ||
GS India Equity Portfolio I Acc | 4.72B | -15.01 | 6.27 | 8.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shriram Finance | INE721A01047 | 3.71 | 678.35 | -0.54% | |
Max Healthcare Institute | INE027H01010 | 3.34 | 1,172.75 | +2.31% | |
Apollo Hospitals | INE437A01024 | 3.31 | 6,644.70 | +0.44% | |
Eternal | INE758T01015 | 3.27 | 209.81 | -5.83% | |
Persistent Systems | INE262H01021 | 2.84 | 5,558.30 | +2.53% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Sell | Sell |
Summary | Strong Buy | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review